Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2015 Dec 17;1863(4):562–571. doi: 10.1016/j.bbamcr.2015.12.008

Fig. 4.

Fig. 4

Combination of GCS-100 and ABT-199 reduces leukemic cells in AML samples. Normal monocytic cells were obtained from a heathy donor and primary leukemia blast cells (N = 3) were treated with vehicle (0.1% DMSO) or 250 µg/ml GCS-100 +/− 0.1 µM ABT-199 for 72 h. Total viable cells (Ann V −/ DAPI – with bead count were determined by FACSCAN analysis. * represents p < 0.05; ** represents p < 0.01, *** represents p < 0.001 as determined by Student t test.